Proton Pump Inhibitors are Risk Factors for Viral Infections: Even for COVID-19? Bruno CharpiatNathalie BleyzacMichel Tod Current Opinion 10 August 2020 Pages: 897 - 899
Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety Young Ran LeeSuyeon Yeo Review Article 22 July 2020 Pages: 901 - 913
Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review Chang-Yu HsiehTsen-Fang Tsai Review Article 21 July 2020 Pages: 915 - 926
Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions Sauzanne KhaliliehKa Lai YeeMarian Iwamoto Review Article Open access 20 August 2020 Pages: 927 - 946
Community-Acquired Bacterial Pneumonia—Changing Epidemiology, Resistance Patterns, and Newer Antibiotics: Spotlight on Delafloxacin Roopali SharmaChristian E. SandrockNicolette Theriault Review Article Open access 05 September 2020 Pages: 947 - 960
The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model Thomas P. LodiseGlenn S. TillotsonJill Massey Original Research Article Open access 10 July 2020 Pages: 961 - 971
Comprehensive Pulmonary Safety Review of Inhaled Technosphere® Insulin in Patients with Diabetes Mellitus Janet B. McGillAnne PetersDavid M. Kendall Original Research Article Open access 27 July 2020 Pages: 973 - 983
Remifentanil Target-Controlled Infusion for Conscious Sedation in Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA): A Case Series Simone ScarlataFabio CostaFelice E. Agrò Research Letter 07 August 2020 Pages: 985 - 988
Use of Azithromycin in COVID-19: A Cautionary Tale Chia Siang KowSyed Shahzad Hasan Letter to the Editor 20 August 2020 Pages: 989 - 990
